Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices 85649 

training to obtain DATA 2000 waivers 

for their physicians and practitioners to 

furnish opioid use disorder treatment 

services. To receive payment, FQHCs 

and RHCs must submit a formal 

application. 

In order to be eligible for payment, as 

well as to provide HRSA with 

information necessary for validation and 

issuance of accurate payments, the form 

requires that FQHCs and RHCs provide 

information identifying the submitting 

organization and the number of 

practitioners who have completed 

training and obtained a DATA 2000 

waiver. The form requires the 

submitting FQHC or RHC to include 

information regarding each claimed 

practitioner’s name, physician or 

practitioner type (e.g., physician, 

physician assistant, nurse practitioner, 

certified nurse midwife, clinical nurse 

specialist, certified registered nurse, or 

anesthetist), National Provider Identifier 

number, Drug Enforcement 

Administration number, state medical 

license number, length of training, date 

the training was completed, date of 

waiver attainment, and DATA 2000 

waiver number. Additionally, the form 

requires signature of an attestation 

statement certifying that (1) each 

practitioner for which the entity is 

seeking payment under the application 

is employed by or working under 

contract for this facility; (2) it is the first 

time the entity is seeking payment on 

behalf of the listed practitioner(s); (3) 

the entity is eligible to seek payment 

under 42 U.S.C. 1395m(o)(3) or 42 

U.S.C. 1395l(bb); (4) each practitioner is 

furnishing opioid use disorder treatment 

services; and (5) that the statements 

herein are true, complete, and accurate 

to the best of the applicant’s knowledge. 

FQHCs and RHCs will need a System for 

Award Management account and a 

HRSA Electronic Handbooks account in 

order to apply (visit https://sam.gov/ 

SAM/ and https://grants.hrsa.gov/2010/ 

WebEPSExternal/Interface/ 

UserRegistration/Registration

Home.aspx?controlName=ContentTabs 

for more information on how to create 

an account). 

A 60-day notice published in the 

Federal Register on October 6, 2020, 

vol. 85, No. 194; pp. 63121–22. There 

were no public comments. 

Need and Proposed Use of the 

Information: The Substance Use— 

Disorder Prevention that Promotes 

Opioid Recovery and Treatment for 

Patients and Communities Act requires 

FQHCs and RHCs to submit to the 

Secretary an application for payment at 

such time, in such manner, and 

containing such information as 

specified by the Secretary in order to 

receive a payment under section 6083. 

This form allows FQHCs and RHCs to 

apply for such payments based on the 

average cost of training to obtain DATA 

2000 waivers, as determined by the 

Secretary, for their physicians and 

practitioners to furnish opioid use 

disorder treatment services. HRSA 

intends to validate and pay $3,000 per 

eligible provider submitted on the form 

by FQHCs and RHCs. The form also 

provides HRSA with the requisite data 

to validate qualifying DATA 2000 

waiver possessions for the purpose of 

ensuring accurate payments to FQHCs 

and RHCs. 

The following changes were made 

since the publication of the 60 Day 

notice. The number of respondents, total 

respondents, and total burden hours 

were updated to reflect administrative 

costs in the agency’s spend plan. The 

figures assume a $3,000 payment for 

each DATA 2000 waiver and $750,000 

in administrative costs, thereby leaving 

$7,250,000 in funds available for 

payment to FQHCs and RHCs. Language 

was added in the ‘‘Need and Proposed 

Use of the Information’’ section to signal 

to stakeholders that HRSA intends to 

validate and pay $3,000 per eligible 

provider submitted on the form by 

FQHCs and RHCs. Additionally, 

language was added in the ‘‘Abstract’’ 

section notifying FQHCs and RHCs that 

they will need a System for Award 

Management account and a HRSA 

Electronic Handbooks account in order 

to apply. 

Likely Respondents: Only FQHC and 

RHC are eligible to apply. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

DATA 2000 Waiver Training Payment Program Application 

for Payment ...................................................................... 2,416 1 2,416 0.5 1,208 

Total .............................................................................. 2, 416 ........................ 2,416 ........................ 1,208 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Amy P. McNulty, 

Deputy Director, Executive Secretariat. 

[FR Doc. 2020–28767 Filed 12–28–20; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990–New] 

Agency Information Collection 

Request; 30-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 


KHAMMOND on DSKJM1Z7X2PROD with NOTICES
85650 Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

Office of the Secretary (OS), Department 

of Health and Human Services, is 

announcing it has submitted to the 

Office of Management and Budget 

(OMB) for review and clearance the 

following collection of information. The 

addresses section has been corrected to 

reflect the correct comments email 

address. 

DATES: Comments on the ICR must be 

received on or before January 28, 2021. 

ADDRESSES: Submit your comments to 

http://www.reginfo.gov/public/do/ 

PRAMain or via facsimile to (202) 395– 

5806. 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When submitting 

comments or requesting information, 

please include the document identifier 

0990-New and project title for reference. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, OS/ 

DHHS has submitted the following 

proposed collection of information to 

OMB for review and clearance. 

OMB No. 0990-New—HHS Teletracking 

COVID–19 Portal; OMB Control 

Number 

Abstract: The data collected through 

this ICR informs the Federal 

Government’s understanding of disease 

patterns and furthers the development 

of policies for prevention and control of 

disease spread and impact related to the 

2019 Novel Coronavirus (COVID–19). 

One of the most important uses of the 

data collected through this ICR is to 

determine critical allocations of limited 

supplies (e.g., protective equipment and 

medication). For instance, this 

collection has been used to distribute 

Remdesivir, a vital therapeutic that HHS 

distributes to the American healthcare 

system, via distinct data calls on regular 

intervals. As of July 10, HHS reduced 

the number requests for data from 

hospitals to support allocations of 

Remdesivir. HHS has stopped sending 

out one-time requests for data to aid in 

the distribution of Remdesivir or any 

other treatments or supplies. This 

consolidated daily reporting is the only 

mechanism used for the distribution 

calculations, and daily reports are 

needed to ensure accurate calculations. 

Type of Respondent: We acknowledge 

the burden placed on many hospitals, 

including resource constraints, and have 

allowed for some flexibilities, such as 

back-submissions or submitting every 

business days, with the understanding 

that respondents may not have 

sufficient staff working over the 

weekend. It is our belief that collection 

of this information daily is the most 

effective way to detect outbreaks and 

needs for Federal assistance over time, 

by hospital and geographical area, and 

to alert the appropriate officials for 

action. It’s requested that 5,500 

hospitals, submit data daily on the 

number of patients tested for COVID–19, 

as well as information on bed capacity 

and requirements for other supplies. 

The HHS Teletracking COVID–19 

Portal (U.S. Healthcare COVID–19 

Portal) includes some data that were 

initially submitted by hospitals to HHS 

through CDC’s National Healthcare 

Safety Network (NHSN) COVID–19 

Module (OMB Control No. 0920–1290, 

approved 03/26/2020). Over the last 

several month’s time, the guidance for 

which data elements should be sent to 

HHS and through which method was 

updated at the request of the White 

House Coronavirus Task Force and 

other leaders to better inform the 

response. 

ESTIMATED ANNUALIZED BURDEN HOURS

Number of 

respondents 

Form name 

(electronic portal) 

Number of 

responses per 

respondents 

Total annual 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

5,500 ................. HHS Teletracking COVID–19 Portal ................................ 365 2,007,500 1.75 3,513,125 

Terry Clark, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. 2020–28787 Filed 12–28–20; 8:45 am] 

BILLING CODE 4150–04–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Comprehensive and Rapid 

Response to NIAID Research Programs (N01), 

Task Area C. 

Date: January 19, 2021. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Kumud Singh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G11, Rockville, MD 

20852, 301–761–7830, kumud.singh@

nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Comprehensive and Rapid 

Response to NIAID Research Programs, Task 

Area D. 

Date: January 21, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Kumud Singh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G11, Rockville, MD 

20852, 301–761–7830, kumud.singh@

nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Comprehensive and Rapid 

Response to NIAID Research Programs, Task 

Area E. 

Date: January 22, 2021. 

Time: 12:00 p.m. to 4:00 p.m. 


KHAMMOND on DSKJM1Z7X2PROD with NOTICES